SEALSQ Corp (NASDAQ:LAES – Get Free Report) saw unusually large options trading activity on Wednesday. Traders purchased 10,077 call options on the company. This is an increase of approximately 54% compared to the average volume of 6,556 call options.
SEALSQ Trading Down 3.8%
LAES opened at $4.25 on Friday. The company has a debt-to-equity ratio of 3.55, a current ratio of 3.58 and a quick ratio of 3.20. The company’s 50 day moving average is $2.87 and its 200 day moving average is $3.23. SEALSQ has a 12-month low of $0.29 and a 12-month high of $11.00.
Hedge Funds Weigh In On SEALSQ
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Private Advisor Group LLC bought a new stake in SEALSQ during the fourth quarter valued at about $84,000. SBI Securities Co. Ltd. bought a new stake in SEALSQ during the fourth quarter valued at about $707,000. Bravias Capital Group LLC bought a new stake in SEALSQ during the fourth quarter valued at about $141,000. HUB Investment Partners LLC purchased a new stake in shares of SEALSQ in the fourth quarter worth $115,000. Finally, Geode Capital Management LLC purchased a new stake in shares of SEALSQ in the fourth quarter worth $79,000. Hedge funds and other institutional investors own 1.25% of the company’s stock.
SEALSQ Company Profile
SEALSQ Corp, together with its subsidiaries, designs, develops, and markets semiconductor chips in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. It offers semiconductors, such as VaultIC secure elements, secure arm platform, and smart card reader chips; identity provisioning services, such as IoT device provisioning and chip provisioning; and managed PKI for IoT solutions and trust services.
Read More
- Five stocks we like better than SEALSQ
- The Most Important Warren Buffett Stock for Investors: His Own
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- What Investors Need to Know to Beat the Market
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Consumer Staples Stocks, Explained
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for SEALSQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SEALSQ and related companies with MarketBeat.com's FREE daily email newsletter.